Literature DB >> 35623876

Reply - Letter to the editor: "Micronutrient supplementation, COVID-19 vaccination and adverse effect".

Rinkoo Dalan1, Bernhard O Boehm2.   

Abstract

Entities:  

Keywords:  COVID-19; Nutritional supplementation; Vaccine

Mesh:

Substances:

Year:  2022        PMID: 35623876      PMCID: PMC8894684          DOI: 10.1016/j.clnesp.2022.02.117

Source DB:  PubMed          Journal:  Clin Nutr ESPEN        ISSN: 2405-4577


× No keyword cloud information.
Dear Editor, The authors, Mungmunpuntipantip R & Wiwanitkit V, have highlighted the concerns of adverse effects of COVID vaccines in thalassemia [1]. We wish to highlight that data specific to the safety and efficacy of COVID-19 vaccines, in thalassemia patients is limited. However, there is significant data to show that COVID infection in thalassemia is associated with significant mortality (>25%) [2,3]. Hence, most international guidelines suggest that the benefits of COVID-19 immunization outweigh any theoretical risks of immunization [4]. With regards to genetic polymorphisms like vitamin D genetic polymorphisms, specific data on the safety and efficacy of COVID-19 vaccines, is limited. However, there is evidence to show that individuals with vitamin D genetic polymorphisms and other polymorphisms in the vitamin D metabolism pathway, are at increased risk for COVID-19 infection severity and mortality [5,6]. There is also evidence to show low pre-infection 25(OH)D concentrations is associated with increased risk of COVID-19 infection severity and mortality [7]. Hence, the benefits of COVID-19 immunization will outweigh any theoretical risks of immunization regardless of underlying vitamin D related genetic polymorphisms and vitamin D deficiency. Moreover, vitamin D supplementation to maintain adequate 25(OH)D concentrations has been suggested to reduce the risk of COVID-19 transmission and infection [8]. We wish to highlight that while we suggest that supplementation will be useful in susceptible patients to reduce the risk of adverse effects in terms of autoimmune re-activation and thrombosis potential with COVID-19 vaccinations, these adverse effects are relatively rare. Hence, we would like to stress on the importance of COVID-19 immunization in the population.

Author contributions

RD and BOB drafted and reviewed this reply. All authors attest they meet the ICMJE criteria for authorship.

Declaration of competing interest

The author declares no potential conflict of interest.
  7 in total

1.  β-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study.

Authors:  Mandana Zafari; Mohammad T S Rad; Fatemeh Mohseni; Nasimeh Nikbakht
Journal:  Hemoglobin       Date:  2020-12-14       Impact factor: 0.849

2.  Effects of vitamin D receptor gene polymorphisms on the prognosis of COVID-19.

Authors:  Tugce Apaydin; Hamza Polat; Ceyda Dincer Yazan; Can Ilgin; Onur Elbasan; Saida Dashdamirova; Feyza Bayram; Elif Tukenmez Tigen; Ozan Unlu; Ahmet F Tekin; Ebru Arslan; Ipek Yilmaz; Goncagul Haklar; Pınar Ata; Hulya Gozu
Journal:  Clin Endocrinol (Oxf)       Date:  2021-12-25       Impact factor: 3.523

Review 3.  Association of vitamin D status with COVID-19 and its severity : Vitamin D and COVID-19: a narrative review.

Authors:  Jae Hyun Bae; Hun Jee Choe; Michael F Holick; Soo Lim
Journal:  Rev Endocr Metab Disord       Date:  2022-01-04       Impact factor: 9.306

4.  Associations between Genetic Variants in the Vitamin D Metabolism Pathway and Severity of COVID-19 among UAE Residents.

Authors:  Fatme Al-Anouti; Mira Mousa; Spyridon N Karras; William B Grant; Zainab Alhalwachi; Laila Abdel-Wareth; Maimunah Uddin; Nawal Alkaabi; Guan K Tay; Bassam Mahboub; Habiba AlSafar
Journal:  Nutrients       Date:  2021-10-20       Impact factor: 5.717

5.  Micronutrient supplementation, COVID-19 vaccination and adverse effect: Correspondence.

Authors:  Rujittika Mungmunpuntipantip; Viroj Wiwanitkit
Journal:  Clin Nutr ESPEN       Date:  2022-02-28

6.  Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness.

Authors:  Amiel A Dror; Nicole Morozov; Amani Daoud; Yoav Namir; Orly Yakir; Yair Shachar; Mark Lifshitz; Ella Segal; Lior Fisher; Matti Mizrachi; Netanel Eisenbach; Doaa Rayan; Maayan Gruber; Amir Bashkin; Edward Kaykov; Masad Barhoum; Michael Edelstein; Eyal Sela
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

7.  Prevalence and mortality in β-thalassaemias due to outbreak of novel coronavirus disease (COVID-19): the nationwide Iranian experience.

Authors:  Mehran Karimi; Sezaneh Haghpanah; Azita Azarkeivan; Zohreh Zahedi; Tahereh Zarei; Maryam Akhavan Tavakoli; Asghar Bazrafshan; Afshan Shirkavand; Vincezo De Sanctis
Journal:  Br J Haematol       Date:  2020-06-30       Impact factor: 8.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.